UK and Ireland Neuroendocrine Tumour Society
NETs Basics Course: A one-day course for trainees and consultants wishing to gain confidence in the investigation and management of patients with neuroendocrine tumours in a multidisciplinary setting.
Gain recognition for your work
Raise your profile
Advance your career development
UKI NETS welcomes new members who have demonstrated an active interest in the management of NETS. Find out how membership can help to to gain recognition for your work, raise your profile and advance your career development.
Our team will be happy to answer any of your queries about our annual event, grants and prizes, and the benefits of membership. Also, please let us know if you have anything you’d like to share in our news section or quarterly bulletin.
Neuroendocrine tumours or NETs, is the umbrella term for a group of relatively uncommon cancers. Around 4,000 new cases are diagnosed every year in the UK, but it is thought that a larger number of people have a NET, but remain undiagnosed.
Read guidance on the management of NETs
The UK and Ireland Neuroendocrine Tumour Society (UKI NETS) aims to promote research, education, training and best clinical practice across a multidisciplinary area in the field of neuroendocrine tumours.
Sign-up for our quarterly email newsletter. Simply give us your email address in the box below to sign-up.
The UK & Ireland Neuroendocrine Tumour Society would like to thank our sponsors for their kind support.
Ipsen – Platinum Sponsor
ITM – Gold Sponsor
Novartis – Silver Sponsor
Intrapharm Laboratories – Bronze Sponsor
AAA/IEL – Meeting Sponsor
Sign up to our Members’ Area for full details of our committees and minutes of meetings.
Join our global community and support worldwide NET Cancer Day on November 10th.
The NET Patient Foundation Society (NPF) aims to promote research, education, training and best clinical practice across a multidisciplinary area in the field of neuroendocrine tumours.
The European Neuroendocrine Tumor Society (ENETS) brings together experts in the field of neuroendocrine cancers from around Europe.
